Search research articles
Contact Us
Filters
Showing results (1-10 of 152) with videos related to
Page
of 16
Sort By:
The Journal of Antimicrobial Chemotherapy
|
July 4, 2002
Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication
Jan Balzarini, Christopher McGuigan
Future Medicinal Chemistry
|
March 31, 2012
Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs
Karolina Madela, Christopher McGuigan
The Journal of Antimicrobial Chemotherapy
|
August 15, 2009
FV100 as a new approach for the possible treatment of varicella-zoster virus infection
Christopher McGuigan, Jan Balzarini
Scandinavian Journal of Infectious Diseases
|
May 28, 2002
Clostridium novyi type A infection: a sporadic fatal case
Christopher McGuigan, Michael Roworth
Antiviral Research
|
May 23, 2006
Aryl furano pyrimidines: the most potent and selective anti-VZV agents reported to date
Christopher McGuigan, Jan Balzarini
Brain and Behavior
|
October 31, 2015
Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients
Iain J McGurgan, Christopher McGuigan
Mini Reviews in Medicinal Chemistry
|
May 12, 2004
Aryloxy phosphoramidate triesters as pro-tides
Dominique Cahard, Christopher McGuigan, Jan Balzarini
Current Neurology and Neuroscience Reports
|
February 13, 2023
Paraneoplastic Neurologic Disorders
Michael Gilligan, Christopher McGuigan, Andrew McKeon
Current Protocols in Nucleic Acid Chemistry
|
March 11, 2015
Symmetrical diamidate prodrugs of nucleotide analogues for drug delivery
Fabrizio Pertusati, Christopher McGuigan, Michaela Serpi
Antiviral Chemistry & Chemotherapy
|
December 21, 2011
Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy
Fabrizio Pertusati, Michaela Serpi, Christopher McGuigan
Page
of 16
Search research articles
Search
Showing results (1-10 of 152) with videos related to
Sort By:
Page
of 16
The Journal of Antimicrobial Chemotherapy
|
July 4, 2002
Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication
Jan Balzarini, Christopher McGuigan
Future Medicinal Chemistry
|
March 31, 2012
Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs
Karolina Madela, Christopher McGuigan
The Journal of Antimicrobial Chemotherapy
|
August 15, 2009
FV100 as a new approach for the possible treatment of varicella-zoster virus infection
Christopher McGuigan, Jan Balzarini
Scandinavian Journal of Infectious Diseases
|
May 28, 2002
Clostridium novyi type A infection: a sporadic fatal case
Christopher McGuigan, Michael Roworth
Antiviral Research
|
May 23, 2006
Aryl furano pyrimidines: the most potent and selective anti-VZV agents reported to date
Christopher McGuigan, Jan Balzarini
Brain and Behavior
|
October 31, 2015
Nonmelanoma skin cancer risk awareness in azathioprine-treated myasthenia gravis patients
Iain J McGurgan, Christopher McGuigan
Mini Reviews in Medicinal Chemistry
|
May 12, 2004
Aryloxy phosphoramidate triesters as pro-tides
Dominique Cahard, Christopher McGuigan, Jan Balzarini
Current Neurology and Neuroscience Reports
|
February 13, 2023
Paraneoplastic Neurologic Disorders
Michael Gilligan, Christopher McGuigan, Andrew McKeon
Current Protocols in Nucleic Acid Chemistry
|
March 11, 2015
Symmetrical diamidate prodrugs of nucleotide analogues for drug delivery
Fabrizio Pertusati, Christopher McGuigan, Michaela Serpi
Antiviral Chemistry & Chemotherapy
|
December 21, 2011
Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy
Fabrizio Pertusati, Michaela Serpi, Christopher McGuigan
Page
of 16